Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?

被引：2
|
作者：
Poletajew, Slawomir [1 ]
Krajewski, Wojciech [2 ]
Kryst, Piotr [1 ]
机构：
[1] Ctr Postgrad Med Educ, Dept Urol 2, 80 Ceglowska St, PL-00809 Warsaw, Poland
[2] Wroclaw Med Univ, Dept Urol & Oncol Urol, Wroclaw, Poland
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2020年 / 9卷 / 06期
关键词：
CISPLATIN-INELIGIBLE PATIENTS; PD-1; BLOCKADE; UROTHELIAL CARCINOMA; CLINICAL-RESPONSE; SOLID TUMORS; SINGLE-ARM; MULTICENTER; SENSITIVITY; EXPRESSION; GUIDELINES;
D O I：
10.21037/tau-20-907
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：2479 / 2482
页数：4
相关论文
共 50 条
  • [31] Immune checkpoint inhibitors for metastatic bladder cancer
    Cubelli, Marta
    Di Nunno, Vincenzo
    Rihawi, Karim
    Massari, Francesco
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S720 - S732
  • [32] CD163 detection in immune check-point inhibitors-related acute interstitial nephritis
    Perier, Thomas
    Renaudineau, Yves
    Pellegrini, Juliette
    Colombat, Magali
    Ramirez, Angie Arango
    Guy, Pierre
    Jamme, Thibaut
    Van Acker, Nathalie
    Kounde, Clement
    Ribes, David
    Huart, Antoine
    Casemayou, Audrey
    Belliere, Julie
    CLINICAL KIDNEY JOURNAL, 2025, 18 (03)
  • [33] Comparison between CT scan evaluation criteria and PERCIST for evaluation of immune check-point inhibitors response
    Rossi, G.
    Genova, C.
    Morbelli, S.
    Rijavec, E.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Mennella, S.
    Dal Bello, M. G.
    Distefano, R.
    Bauckneht, M.
    Tagliamento, M.
    Cittadini, G.
    Merlo, D. F.
    Sambuceti, G.
    Grossi, F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 162 - 162
  • [34] Comparison between CT Scan Evaluation Criteria and PERCIST for Evaluation of Immune Check-Point Inhibitors Response
    Rossi, Giovanni
    Genova, Carlo
    Morbelli, Silvia
    Rijavec, Erka
    Barletta, Giulia
    Biello, Federica
    Maggioni, Claudia
    Mennella, Simone
    Dal Bello, Maria Giovanna
    Distefano, Roberta
    Bauckneht, Matteo
    Cittadini, Giuseppe
    Merlo, Franco
    Sambuceti, Gianmario
    Grossi, Francesco
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S401 - S402
  • [35] Molecular features for selecting Asian metastatic melanoma patients who benefit from check-point inhibitors.
    Byeon, Seonggyu
    Kim, Hyera
    Yeo, Ja Hyun
    Kim, Jinchul
    Kwon, Minsuk
    Lee, Jiyun
    Kim, Seung Tae
    Lee, Jeeyun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Completely cured bone metastasis using radiation therapy, denosumab, and immune check-point inhibitors (Nivolumab Plus Ipilimumab): a case report
    Mukouyama, H.
    Nakasone, K.
    Manabe, Y.
    Hashimoto, S.
    Yoshimi, N.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 190 - 190
  • [37] Rare targetable drivers (RTDs) in non-small cell lung cancer (NSCLC): Outcomes with immune check-point inhibitors (ICPi)
    Dudnik, Elizabeth
    Bshara, Elias
    Grubstein, Ahuva
    Fridel, Ludmila
    Shochat, Tzippy
    Roisman, Laila C.
    Ilouze, Maya
    Rozenblum, Anna Belilovski
    Geva, Smadar
    Zer, Alona
    Rotem, Ofer
    Allen, Aaron M.
    Peled, Nir
    LUNG CANCER, 2018, 124 : 117 - 124
  • [38] Chemotherapy and immune check point inhibitors in the management of cervical cancer
    Kumar, Lalit
    Upadhyay, Avinash
    Jayaraj, Aarthi S.
    CURRENT PROBLEMS IN CANCER, 2022, 46 (06)
  • [39] The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker
    Tu, Zewei
    Wang, Xiaolin
    Cai, Huan
    Sheng, Yilei
    Wu, Lei
    Huang, Kai
    Zhu, Xingen
    AGING-US, 2023, 15 (06): : 2136 - 2157
  • [40] Management of immune check-point inhibitor-associated colitis in patients with advanced metastatic cancers: A review article
    Tauseef, Abubakar
    Zafar, Maryam
    Siddiqui, Sameed Abdul Hameed
    Dufani, Jalal
    DeVrieze, Bradley
    Mirza, Muazzam
    Thirumalareddy, Joseph
    Sood, Akshat
    Mirza, Mohsin
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (07) : 2562 - 2567
12345